Real-World Eculizumab Dosing Patterns Among Patients with Paroxysmal Nocturnal Hemoglobinuria in a US Population

Authors Cheng WY, Sarda SP, Mody-Patel N, Krishnan S, Yenikomshian M, Kunzweiler C, Vu JD, Cheung HC , Duh MS  Received 6 November 2021 Accepted for publication 12 April 2022 Published 3 May 2022 Volume 2022:14 Pages 357—369 DOI https://doi.org/10.2147/CEOR.S346816 Checked for plagiarism Yes Review...

EVERSANA™ and Vector Pharma FZCO Announce Strategic Partnership to Expand Commercialisation Services Throughout Middle East and North Africa

CHICAGO and DUBAI, UAE, April 28, 2022 /PRNewswire/ — EVERSANA™, the pioneer of next-generation commercial services to the global life sciences industry, and Vector Pharma FZCO of Dubai UAE, the leading full-service distributor for rare disease, oncology, and...